2021 Media Kit
Journal of Immunotherapy
Website
http://www.immunotherapy-journal.com/
Content Focus
Journal of Immunotherapy features rapid publication of articles on immunomodulators, lymphokines, antibodies, cells, and cell products in cancer biology and therapy. Laboratory and preclinical studies, as well as investigative clinical reports, are presented. The journal emphasizes basic mechanisms and methods for the rapid transfer of technology from the laboratory to the clinic. Journal of Immunotherapy contains full-length articles, review articles, and short communications.
Impact Factor
4.110
Impact Factor Ranking
Oncology 85/244
Immunology 56/158
Medicine, Research, and Experimental 47/138
Editor-in-Chief
Steven A. Rosenberg, MD, PhD
Frequency
9 issues per year
Advertising Guidelines
Subject to approval by Editor. New copy must be received by the Publisher two weeks before closing date.